Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.0615
Abstract: This systematic review and meta-analysis evaluates whether, for patients with poorly controlled asthma, switching to single inhaler combination budesonide-formoterol maintenance and reliever therapy is associated with longer time to first severe asthma exacerbation compared with… read more here.
Keywords: poorly controlled; maintenance; patients poorly; controlled asthma ... See more keywords
Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial
Sign Up to like & getrecommendations! Published in 2017 at "Advances in Therapy"
DOI: 10.1007/s12325-017-0604-x
Abstract: IntroductionChronic obstructive pulmonary disease is associated with a high healthcare resource and cost burden. Healthcare resource utilization was analyzed in patients with symptomatic chronic obstructive pulmonary disease at risk of exacerbations in the FULFIL study.… read more here.
Keywords: resource utilization; healthcare resource; furoate umeclidinium; budesonide formoterol ... See more keywords
Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2019.1665514
Abstract: ABSTRACT Introduction: Inhaled corticosteroid (ICS) plus long-acting β2-agonist (LABA) combinations are commonly used in the treatment of patients with chronic obstructive pulmonary disease (COPD). At least four fixed-dose ICS/LABA combinations are available, including budesonide/formoterol, beclomethasone/formoterol,… read more here.
Keywords: formoterol; long acting; inhaled corticosteroid; plus long ... See more keywords
Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open Respiratory Research"
DOI: 10.1136/bmjresp-2022-001271
Abstract: Background In randomised controlled trials, as-needed inhaled corticosteroid (ICS)-formoterol reliever therapy reduces severe exacerbation risk compared with maintenance ICS plus short-acting beta2-agonist (SABA) reliever in adolescent and adult asthma, but results in slightly worse control… read more here.
Keywords: maintenance; asthma control; control; versus maintenance ... See more keywords
Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Respiratory Disease"
DOI: 10.1177/17534666221107312
Abstract: Background and aims: Low peak inspiratory flow (PIF) is common following severe exacerbations of chronic obstructive pulmonary disease (COPD). Patients with COPD and low PIF may be at risk of suboptimal delivery of inhaled therapies… read more here.
Keywords: fumarate dihydrate; formoterol fumarate; lung function; week ... See more keywords
Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: a randomised crossover trial
Sign Up to like & getrecommendations! Published in 2022 at "European Respiratory Journal"
DOI: 10.1183/13993003.02309-2021
Abstract: Background Our objective was to determine the comparative bronchodilator, systemic β2-agonist, cardiovascular and adverse effects of salbutamol 200 µg and budesonide/formoterol 200/6 µg when taken repeatedly in stable asthma. Methods This open-label, crossover, single-centre, controlled trial randomised… read more here.
Keywords: formoterol; formoterol 200; min; salbutamol 200 ... See more keywords
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2020.5237
Abstract: Introduction: In asthma, maintenance and reliever therapy (MART) with inhaled corticosteroid (ICS)/formoterol reduces exacerbations compared to fixed-dose therapy with ICS/long-acting β2-agonist. No studies have investigated MART in patients with chronic obstructive pulmonary disease (COPD). Methods:… read more here.
Keywords: maintenance reliever; therapy; dose therapy; reliever therapy ... See more keywords
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Sign Up to like & getrecommendations! Published in 2020 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-020-05440-6
Abstract: Objectives To investigate the incidence of active tuberculosis (TB) among COPD patients using fluticasone/salmeterol or budesonide/formoterol, and to identify any differences between these two groups of patients. Methods The study enrolled COPD patients from Taiwan… read more here.
Keywords: copd patients; budesonide formoterol; fluticasone salmeterol; group ... See more keywords
Stepped treatment algorithm using budesonide-formoterol for chronic respiratory diseases: A single arm interventional study
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0271178
Abstract: Background While the safety and efficacy of inhaled budesonide-formoterol, used as-needed for symptoms, has been established for patients with asthma, it has not been trialed in undifferentiated patients with chronic respiratory diseases. We aimed to… read more here.
Keywords: inhaled budesonide; formoterol; algorithm; chronic respiratory ... See more keywords
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
Sign Up to like & getrecommendations! Published in 2021 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s300704
Abstract: [This corrects the article DOI: 10.2147/DDDT.S266177.]. read more here.
Keywords: formoterol anti; reliever maintenance; anti inflammatory; inflammatory reliever ... See more keywords
Budesonide/formoterol versus salmeterol/fluticasone for asthma in children: an effectiveness and safety analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of comparative effectiveness research"
DOI: 10.2217/cer-2021-0142
Abstract: Background: The efficacy of budesonide + formoterol therapy compared with high-dose salmeterol + fluticasone therapy plus short-acting β-agonist (SABA) has not been evaluated specifically in children. Objectives: To evaluate the efficacy and safety of budesonide + formoterol combination therapy two times a day… read more here.
Keywords: therapy; budesonide formoterol; salmeterol fluticasone;